Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 0703-0110

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0703-0110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydromorphone 01)

Chemical structure diagram of Hydromorphone Hydrochloride, showing the molecular arrangement of its atoms and bonds including a hydrochloride (HCl) component.*

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL, a 1 mL single-dose vial. The label indicates it is a high potency formulation for prescription use only. Manufactured for Teva Pharmaceuticals USA, Inc., North Wales, PA. The label includes a barcode and QR code, lot/expiration placeholders, and revision date 9/2020.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Packaging label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL. The label indicates a high potency formulation and contains 10 single-dose 1 mL vials. Manufactured by Teva Pharmaceuticals USA, Inc., the product is intended for intramuscular, intravenous, and subcutaneous use. The label includes storage instructions, ingredient details, and a barcode.*

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection, USP, 50 mg per 5 mL (10 mg/mL) in a 5 mL single-dose vial. It is a high potency formulation (HPF) intended for Rx only and made for Teva Pharmaceuticals USA, Inc., North Wales, PA. The label states use for preparation of large-volume parenteral solutions and includes an NDC number and space for lot and expiration dates.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Packaging label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL, 50 mg per 5 mL solution in 10 x 5 mL single-dose vials. The label states it is a high potency formulation (HPF) for use in preparing large-volume parenteral solutions. Labeler is Teva Parenteral Medicines, Inc., and it includes storage instructions and handling precautions. The product is for injection via intramuscular, intravenous, or subcutaneous routes.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection USP, 500 mg per 50 mL (10 mg/mL) solution for injection. It is a 50 mL single-dose vial of high potency formulation, supplied by Teva Parenteral Medicines, Inc. The label includes storage instructions, lot number, expiration date areas, and an NDC number 0703-0018-01.*

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Packaging label for Hydromorphone Hydrochloride Injection, USP 500 mg/50 mL (10 mg/mL) high potency formulation in a 50 mL single-dose vial. Label includes drug name, strength, dosage form, storage instructions, and manufacturer Teva Pharmaceuticals USA, Inc. The label also indicates use for preparation of large-volume parenteral solutions and storage temperature details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.